Transcend Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$721K Buy
2,703
+203
+8% +$55K 0.06% 300
2025
Q4
$627K Sell
2,500
-205
-8% -$54.4K 0.05% 323
2025
Q3
$776K Sell
2,705
-350
-11% -$93.8K 0.05% 294
2025
Q2
$802K Sell
3,055
-227
-7% -$55.3K 0.06% 263
2025
Q1
$764K Buy
3,282
+292
+10% +$70.9K 0.05% 298
2024
Q4
$686K Buy
2,990
+69
+2% +$15.8K 0.05% 293
2024
Q3
$653K Buy
2,921
+634
+28% +$139K 0.04% 336
2024
Q2
$465K Buy
2,287
+889
+64% +$181K 0.03% 377
2024
Q1
$305K Buy
1,398
+91
+7% +$20K 0.02% 408
2023
Q4
$297K Sell
1,307
-213
-14% -$44.7K 0.03% 393
2023
Q3
$306K Sell
1,520
-217
-12% -$45.8K 0.03% 369
2023
Q2
$360K Buy
1,737
+107
+7% +$20.8K 0.03% 343
2023
Q1
$321K Buy
+1,630
New +$335K 0.03% 353
2022
Q4
Sell
-1,834
Closed -$323K 513
2022
Q3
$323K Buy
1,834
+542
+42% +$111K 0.04% 354
2022
Q2
$260K Buy
1,292
+57
+5% +$12.2K 0.03% 405
2022
Q1
$280K Buy
+1,235
New +$290K 0.03% 411

Other funds holding LH

Transcend Capital Advisors's LH Position: Q1 2026 in Review

Transcend Capital Advisors increased its Labcorp (LH) stake by 8.1% in Q1 2026, buying an estimated $55K and bringing the position to 2,703 shares worth $721K. The position accounts for 0.06% of the portfolio, ranked #300.

Transcend Capital Advisors first reported a position in LH in Q1 2022 and has held it in 16 quarters since. The position peaked at $802K in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Transcend Capital Advisors held 2,703 shares of Labcorp worth $721K as of Q1 2026.
  • Transcend Capital Advisors bought 203 Labcorp shares in Q1 2026, an estimated $55K.
  • Labcorp made up 0.06% of Transcend Capital Advisors's portfolio in Q1 2026, its #300 holding.
  • Transcend Capital Advisors first reported a position in Labcorp in Q1 2022 and has held it in 16 quarters since.
  • Transcend Capital Advisors's Labcorp position peaked at $802K in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.